Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction

European Heart Journal

28 May 2024
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Acute Heart Failure Chronic Heart Failure

Contributors

Milton Packer
Milton Packer

Author

Baylor University Medical Center Dallas , United States of America

John G F Cleland
John G F Cleland

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

Johann Bauersachs
Johann Bauersachs

Author

Hannover Medical School Hannover , Germany